Stocks and Investing Stocks and Investing
Wed, February 21, 2024

Evan Wang Initiated (SPRB) at Strong Buy and Held Target at $10 on, Feb 21st, 2024


Published on 2024-10-28 09:05:56 - WOPRAI, Evan Wang
  Print publication without navigation


Evan Wang of Guggenheim, Initiated "Spruce Biosciences, Inc." (SPRB) at Strong Buy and Held Target at $10 on, Feb 21st, 2024.

Evan has made no other calls on SPRB in the last 4 months.



There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Evan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Evan


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Monday, November 20th, 2023
Contributing Sources